These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15947009)

  • 61. Dual screening.
    Johnson WO; Pearson LM
    Biometrics; 1999 Sep; 55(3):867-73. PubMed ID: 11315019
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Assessing disease prevalence from inaccurate test results: teaching an old dog new tricks.
    Taragin MI; Wildman D; Trout R
    Med Decis Making; 1994; 14(4):369-73. PubMed ID: 7808211
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Southern states have largest number of AIDS cases.
    J Natl Med Assoc; 1999 Jan; 91(1):13. PubMed ID: 10063783
    [No Abstract]   [Full Text] [Related]  

  • 64. What is the purpose of HIV antibody testing?
    Trussell J
    Soc Biol; 1989; 36(1-2):102-9. PubMed ID: 2683117
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Improving estimates of prevalence by repeated testing.
    McClish D; Quade D
    Biometrics; 1985 Mar; 41(1):81-9. PubMed ID: 4005389
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Studies of AIDS and HIV surveillance. Screening tests: can we get more by doing less?
    Tu XM; Litvak E; Pagano M
    Stat Med; 1994 Oct 15-30; 13(19-20):1905-19. PubMed ID: 7846399
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Estimating and Projecting Trends in HIV/AIDS Generalized Epidemics Using Incremental Mixture Importance Sampling.
    Raftery AE; Bao L
    Biometrics; 2010 Dec; 66(4):1162-73. PubMed ID: 20222935
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Estimation of prevalence on the basis of screening tests.
    Lew RA; Levy PS
    Stat Med; 1989 Oct; 8(10):1225-30. PubMed ID: 2814071
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence estimation when disease status is verified only among test positives: Applications in HIV screening programs.
    G Thomas E; B Peskoe S; Spiegelman D
    Stat Med; 2018 Mar; 37(7):1101-1114. PubMed ID: 29230839
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay.
    Vradi E; Jaki T; Vonk R; Brannath W
    Stat Methods Med Res; 2019 Aug; 28(8):2538-2556. PubMed ID: 29966502
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard.
    Joseph L; Gyorkos TW; Coupal L
    Am J Epidemiol; 1995 Feb; 141(3):263-72. PubMed ID: 7840100
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevalence estimation from pooled samples.
    Sacks JM; Bolin SR; Crowder SV
    Am J Vet Res; 1989 Feb; 50(2):205-6. PubMed ID: 2785780
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Japan screens donated blood.
    Swinbanks D
    Nature; 1986 Feb 20-26; 319(6055):610. PubMed ID: 3951534
    [No Abstract]   [Full Text] [Related]  

  • 74. Generalized additive regression for group testing data.
    Liu Y; McMahan CS; Tebbs JM; Gallagher CM; Bilder CR
    Biostatistics; 2021 Oct; 22(4):873-889. PubMed ID: 32061081
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The first positive: computing positive predictive value at the extremes.
    Smith JE; Winkler RL; Fryback DG
    Ann Intern Med; 2000 May; 132(10):804-9. PubMed ID: 10819704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rational use of diagnostic and screening tests.
    McKenzie BA
    J Small Anim Pract; 2021 Nov; 62(11):1016-1021. PubMed ID: 34196003
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Problem With Predicting Uncommon Events: The Critical Effect of Prevalence in Test Performance.
    Budhiraja P; Heilman RL; Edwards AS; Kaplan B
    Transplant Proc; 2022 Sep; 54(7):1742-1744. PubMed ID: 35918194
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The apparent prevalence, the true prevalence.
    Habibzadeh F; Habibzadeh P; Yadollahie M
    Biochem Med (Zagreb); 2022 Jun; 32(2):020101. PubMed ID: 35799992
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response.
    Nikiforuk AM; McMillan B; Bartlett SR; Márquez AC; Pidduck T; Kustra J; Goldfarb DM; Barakauskas V; Sinclair G; Patrick DM; Sadarangani M; Ogilvie GS; Krajden M; Morshed M; Sekirov I; Jassem AN
    Microbiol Spectr; 2022 Apr; 10(2):e0140521. PubMed ID: 35266818
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Estimating the prevalence of multiple diseases from two-stage hierarchical pooling.
    Warasi MS; Tebbs JM; McMahan CS; Bilder CR
    Stat Med; 2016 Sep; 35(21):3851-64. PubMed ID: 27090057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.